SERF SAS

Stryker (NYSE: SYK) + announced today that it completed its previously announced acquisition of joint replacement company SERF SAS.

In December, the Kalamazoo, Michigan-based orthopedic giant struck a deal to buy the France-based company from Menix.

SERF SAS develops, manufactures and sells a range of large joint replacement products on an international basis. This includes inventing the original Dual Mobility Cup for hip replacement. SERF SAS has its main office in Décines-Charpieu, France.

“The acquisition of SERF SAS further strengthens our global portfolio and reinforces our dedication to orthopaedic excellence,” said Katherine Truppi, president of Stryker’s Joint Replacement division. “We welcome the SERF SAS team to Stryker and look forward to working together to help advance product innovation and customer satisfaction.”

SERF SAS complements Stryker’s existing pr…

Stryker (NYSE: SYK) + announced today that it executed a binding offer to acquire SERF SAS, a France-based joint replacement company.

The Kalamazoo, Michigan-based orthopedic giant executed the offer with Menix, a leader in the dual mobility and first intention stem markets in France.

SERF SAS develops, manufactures and sells a range of large joint replacement products on an international basis. Since its founding, which dates back more than 50 years, the company developed a number of “innovative concepts,” Stryker says. This includes inventing the original Dual Mobility Cup for hip replacement, according to a news release. SERF SAS has its main office in Décines-Charpieu, France.

Stryker said SERF SAS has global recognition from healthcare professionals as an innovator in the hip implant space. The company believes the acquisition complements its existing presence in France and in Europe as well. It…